Healthcare,Healthcare sector projects by Piramal Enterprises Limited in
Project Information
5314
Piramal Enterprises Limited
Piramal Healthcare is investing $11 million (Rs 70 crore) at its Morpeth, UK facility to triple the production capacity for hormonal products, including contraceptive pills and hormone replacement therapies. Work on the new suite, which will house formulation, packaging coating and tableting equipment, will commence at the end of 2013. Piramal Healthcare’s recent plans to invest $2.5 million at its FDA approved Grangemouth, UK, site to upgrade one of its antibody drug conjugate (ADC) manufacturing suites. The 13,000 sq ft Morpeth facility, acquired by Piramal from Pfizer in 2006, also houses Active Pharmaceutical Ingredient (API) production.
Project Value
INR 70 Crore /-
Conceptual Stage
Not Specified
India
Healthcare,Healthcare
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
